Literature DB >> 15367526

Circulating malondialdehyde modified LDL is a biochemical risk marker for coronary artery disease.

T Amaki, T Suzuki, F Nakamura, D Hayashi, Y Imai, H Morita, K Fukino, T Nojiri, S Kitano, N Hibi, T Yamazaki, R Nagai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15367526      PMCID： PMC1768480          DOI： 10.1136/hrt.2003.018226

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  5 in total

Review 1.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

2.  Distribution of immunoreactive malondialdehyde-modified low-density lipoprotein in human serum.

Authors:  K Kotani; M Maekawa; T Kanno; A Kondo; N Toda; M Manabe
Journal:  Biochim Biophys Acta       Date:  1994-11-17

Review 3.  The pathogenesis of atherosclerosis: a perspective for the 1990s.

Authors:  R Ross
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

4.  Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages.

Authors:  A M Fogelman; I Shechter; J Seager; M Hokom; J S Child; P A Edwards
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

5.  Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits.

Authors:  M E Haberland; D Fong; L Cheng
Journal:  Science       Date:  1988-07-08       Impact factor: 47.728
  5 in total
  15 in total

1.  Oxidant and antioxidant status in coronary artery disease.

Authors:  Abdolhossein Bastani; Sadegh Rajabi; Afshin Daliran; Habibollah Saadat; Feridoun Karimi-Busheri
Journal:  Biomed Rep       Date:  2018-07-17

2.  Impact of malondialdehyde-modified low-density lipoprotein on coronary plaque vulnerability in patients not receiving lipid-lowering therapy: a whole coronary analysis with multislice-computed tomography.

Authors:  Tsuyoshi Ito; Taku Ichihashi; Hiroshi Fujita; Tomonori Sugiura; Nobuyuki Ohte
Journal:  Heart Vessels       Date:  2017-10-24       Impact factor: 2.037

3.  Immune Complexes and the Risk of CVD in Type 1 Diabetes.

Authors:  Maria F Lopes-Virella; Ionut Bebu; Kelly J Hunt; Gabriel Virella; Nathaniel L Baker; Barbara Braffett; Xiaoyu Gao; John M Lachin
Journal:  Diabetes       Date:  2019-06-19       Impact factor: 9.461

Review 4.  Cholesterol Metabolism in CKD.

Authors:  Allison B Reiss; Iryna Voloshyna; Joshua De Leon; Nobuyuki Miyawaki; Joseph Mattana
Journal:  Am J Kidney Dis       Date:  2015-09-01       Impact factor: 8.860

Review 5.  Oxidative Stress in Human Atherothrombosis: Sources, Markers and Therapeutic Targets.

Authors:  Jose Luis Martin-Ventura; Raquel Rodrigues-Diez; Diego Martinez-Lopez; Mercedes Salaices; Luis Miguel Blanco-Colio; Ana M Briones
Journal:  Int J Mol Sci       Date:  2017-11-03       Impact factor: 5.923

Review 6.  Phytochemical Constituents, Health Benefits, and Industrial Applications of Grape Seeds: A Mini-Review.

Authors:  Zheng Feei Ma; Hongxia Zhang
Journal:  Antioxidants (Basel)       Date:  2017-09-15

7.  Redox homeostasis in stomach medium by foods: The Postprandial Oxidative Stress Index (POSI) for balancing nutrition and human health.

Authors:  Joseph Kanner; Jacob Selhub; Adi Shpaizer; Boris Rabkin; Inbal Shacham; Oren Tirosh
Journal:  Redox Biol       Date:  2017-04-24       Impact factor: 11.799

8.  Oxidants and antioxidants in myocardial infarction (MI): Investigation of ischemia modified albumin, malondialdehyde, superoxide dismutase and catalase in individuals diagnosed with ST elevated myocardial infarction (STEMI) and non-STEMI (NSTEMI).

Authors:  Nesim Aladağ; Ramazan Asoğlu; Mahmut Ozdemir; Emin Asoğlu; Atabey Rukiye Derin; Canan Demir; Halit Demir
Journal:  J Med Biochem       Date:  2021-06-05       Impact factor: 3.402

9.  Using Anti-Malondialdehyde Modified Peptide Autoantibodies to Import Machine Learning for Predicting Coronary Artery Stenosis in Taiwanese Patients with Coronary Artery Disease.

Authors:  Yu-Cheng Hsu; I-Jung Tsai; Hung Hsu; Po-Wen Hsu; Ming-Hui Cheng; Ying-Li Huang; Jin-Hua Chen; Meng-Huan Lei; Ching-Yu Ling
Journal:  Diagnostics (Basel)       Date:  2021-05-26

10.  Enhanced status of inflammation and endothelial activation in subjects with familial hypercholesterolaemia and their related unaffected family members: a case control study.

Authors:  Thuhairah Rahman; Nur Suhana Hamzan; Atiqah Mokhsin; Radzi Rahmat; Zubin Othman Ibrahim; Rafezah Razali; Malathi Thevarajah; Hapizah Nawawi
Journal:  Lipids Health Dis       Date:  2017-04-24       Impact factor: 3.876
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.